Key Details
Price
$75.36Last Dividend
$0.08Annual ROE
8.33%Beta
1.08Events Calendar
Next earnings date:
Jan 31, 2025Recent quarterly earnings:
Oct 30, 2024Recent annual earnings:
Aug 07, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Nov 08, 2024Next split:
N/ARecent split:
Nov 30, 2022Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
TECH is experiencing ongoing growth in its Diagnostics and Spatial Biology division.
On Wednesday, Bio-Techne exceeded profit expectations for the first quarter, thanks to growth in its diagnostics and spatial biology areas. This news caused the biotech company's shares to rise by 4.59% in premarket trading.
On October 29, 2024, in St. Paul, Minnesota, ScaleReady, together with Wilson Wolf Manufacturing and Bio-Techne Corporation, announced that Luminary Therapeutics has received a G-Rex® Grant worth $300,000.
A new training program is being introduced to address the increasing need for Hyundai and Genesis automotive technicians across the country. This initiative aims to prepare more skilled workers for these roles. It responds to the rising demand in the automotive industry.
SCOTTSDALE, Ariz., Oct. 10, 2024 /PRNewswire/ -- Cyber Enviro-Tech Inc. (CETI) (OTCQB: CETI) is excited to share that it has formed a partnership with its subsidiary, CETI Axenic (CAX), which is owned by its shareholders, to explore possibilities in the commercial laundry sector.
The award will help with the clinical production of the Company's promising Neutrophil-only Leukocyte Infusion Therapy (N-LIfT) platform in St. Paul, Minnesota.
On October 8, 2024, in St. Paul, Minnesota, ScaleReady™ announced a partnership with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH), and CellReady™. They revealed that Eric Tran, Ph.D., is now an Associate Member of the Earle A.
On October 7, 2024, in St. Paul, Minnesota, ScaleReady™ announced a partnership with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH), and CellReady™. Christopher A. was mentioned in their announcement.
On September 18, 2024, in St. Paul, Minnesota, ScaleReady™ announced a partnership with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH), and CellReady™ to work with ImmunoScape Pte.
NEW ORLEANS, LA / ACCESSWIRE / September 12, 2024 / Kahn Swick & Foti, LLC ("KSF") and their partner, former Louisiana Attorney General Charles C. Foti, Jr., want to remind investors that the deadline to submit lead plaintiff applications in a securities class action lawsuit against ODDITY Tech Ltd. is September 17, 2024.
FAQ
- What is the primary business of Bio-Techne?
- What is the ticker symbol for Bio-Techne?
- Does Bio-Techne pay dividends?
- What sector is Bio-Techne in?
- What industry is Bio-Techne in?
- What country is Bio-Techne based in?
- When did Bio-Techne go public?
- Is Bio-Techne in the S&P 500?
- Is Bio-Techne in the NASDAQ 100?
- Is Bio-Techne in the Dow Jones?
- When was Bio-Techne's last earnings report?
- When does Bio-Techne report earnings?
- Should I buy Bio-Techne stock now?